JP2010520785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520785A5 JP2010520785A5 JP2009552832A JP2009552832A JP2010520785A5 JP 2010520785 A5 JP2010520785 A5 JP 2010520785A5 JP 2009552832 A JP2009552832 A JP 2009552832A JP 2009552832 A JP2009552832 A JP 2009552832A JP 2010520785 A5 JP2010520785 A5 JP 2010520785A5
- Authority
- JP
- Japan
- Prior art keywords
- coating
- derivatives
- stent
- medical device
- bioabsorbable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims description 109
- 238000000576 coating method Methods 0.000 claims description 82
- 239000011248 coating agent Substances 0.000 claims description 80
- 239000003814 drug Substances 0.000 claims description 35
- 229940079593 drug Drugs 0.000 claims description 34
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 claims description 27
- 229930012538 Paclitaxel Natural products 0.000 claims description 26
- JVHIPYJQMFNCEK-UHFFFAOYSA-N cytochalasin Chemical class N1C(=O)C2(C(C=CC(C)CC(C)CC=C3)OC(C)=O)C3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 JVHIPYJQMFNCEK-UHFFFAOYSA-N 0.000 claims description 26
- 229960001592 paclitaxel Drugs 0.000 claims description 26
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 26
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical class O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 26
- 150000004579 taxol derivatives Chemical class 0.000 claims description 26
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Chemical class 0.000 claims description 25
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 25
- ZMAODHOXRBLOQO-UHFFFAOYSA-N cytochalasin-A Chemical class N1C(=O)C23OC(=O)C=CC(=O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 ZMAODHOXRBLOQO-UHFFFAOYSA-N 0.000 claims description 24
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 14
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 14
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 claims description 14
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical class C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 claims description 14
- 229940127215 low-molecular weight heparin Drugs 0.000 claims description 14
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 claims description 13
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 13
- 229960003009 clopidogrel Drugs 0.000 claims description 13
- 229940072645 coumadin Drugs 0.000 claims description 13
- 229960002768 dipyridamole Drugs 0.000 claims description 13
- 229960002897 heparin Drugs 0.000 claims description 13
- 229920000669 heparin Polymers 0.000 claims description 13
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Chemical class COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 13
- 229960002930 sirolimus Drugs 0.000 claims description 13
- 229960005080 warfarin Drugs 0.000 claims description 13
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 11
- 229920000954 Polyglycolide Polymers 0.000 claims description 11
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 11
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 11
- 238000003780 insertion Methods 0.000 claims description 10
- 230000037431 insertion Effects 0.000 claims description 10
- 239000003055 low molecular weight heparin Substances 0.000 claims description 10
- GSNOZLZNQMLSKJ-UHFFFAOYSA-N Trapidil Chemical class CCN(CC)C1=CC(C)=NC2=NC=NN12 GSNOZLZNQMLSKJ-UHFFFAOYSA-N 0.000 claims description 9
- -1 trapidyl derivatives Chemical class 0.000 claims description 8
- 229960000363 trapidil Drugs 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000003511 endothelial effect Effects 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 229920000117 poly(dioxanone) Polymers 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 230000003796 beauty Effects 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229910000691 Re alloy Inorganic materials 0.000 claims 1
- 229910001362 Ta alloys Inorganic materials 0.000 claims 1
- 229910001297 Zn alloy Inorganic materials 0.000 claims 1
- 229910001093 Zr alloy Inorganic materials 0.000 claims 1
- DZZDTRZOOBJSSG-UHFFFAOYSA-N [Ta].[W] Chemical compound [Ta].[W] DZZDTRZOOBJSSG-UHFFFAOYSA-N 0.000 claims 1
- 239000002628 heparin derivative Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- QRNPTSGPQSOPQK-UHFFFAOYSA-N magnesium zirconium Chemical compound [Mg].[Zr] QRNPTSGPQSOPQK-UHFFFAOYSA-N 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229910001092 metal group alloy Inorganic materials 0.000 claims 1
- YUSUJSHEOICGOO-UHFFFAOYSA-N molybdenum rhenium Chemical compound [Mo].[Mo].[Re].[Re].[Re] YUSUJSHEOICGOO-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 description 126
- 229920000052 poly(p-xylylene) Polymers 0.000 description 34
- GUHKMHMGKKRFDT-UHFFFAOYSA-N 1785-64-4 Chemical compound C1CC(=C(F)C=2F)C(F)=C(F)C=2CCC2=C(F)C(F)=C1C(F)=C2F GUHKMHMGKKRFDT-UHFFFAOYSA-N 0.000 description 17
- VRBFTYUMFJWSJY-UHFFFAOYSA-N 28804-46-8 Chemical compound ClC1CC(C=C2)=CC=C2C(Cl)CC2=CC=C1C=C2 VRBFTYUMFJWSJY-UHFFFAOYSA-N 0.000 description 17
- 229960000074 biopharmaceutical Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 9
- 229920001661 Chitosan Polymers 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 229920002988 biodegradable polymer Polymers 0.000 description 9
- 239000004621 biodegradable polymer Substances 0.000 description 9
- RDYMFSUJUZBWLH-UHFFFAOYSA-N endosulfan Chemical compound C12COS(=O)OCC2C2(Cl)C(Cl)=C(Cl)C1(Cl)C2(Cl)Cl RDYMFSUJUZBWLH-UHFFFAOYSA-N 0.000 description 9
- 239000005038 ethylene vinyl acetate Substances 0.000 description 9
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 9
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 9
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 7
- 239000003146 anticoagulant agent Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000013270 controlled release Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 229920000544 Gore-Tex Polymers 0.000 description 2
- 208000008883 Patent Foramen Ovale Diseases 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000001262 anti-secretory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007737 ion beam deposition Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90617407P | 2007-03-09 | 2007-03-09 | |
| US60/906,174 | 2007-03-09 | ||
| PCT/US2008/055766 WO2008112458A2 (en) | 2007-03-09 | 2008-03-04 | Bioabsorbable coatings for medical devices |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010520785A JP2010520785A (ja) | 2010-06-17 |
| JP2010520785A5 true JP2010520785A5 (enExample) | 2012-12-06 |
| JP5461202B2 JP5461202B2 (ja) | 2014-04-02 |
Family
ID=39760313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552832A Expired - Fee Related JP5461202B2 (ja) | 2007-03-09 | 2008-03-04 | 医療用具用生体吸収性コーティング |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2124817B8 (enExample) |
| JP (1) | JP5461202B2 (enExample) |
| AU (1) | AU2008226624B2 (enExample) |
| CA (1) | CA2680229A1 (enExample) |
| WO (1) | WO2008112458A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8679517B2 (en) | 2002-09-26 | 2014-03-25 | Palmaz Scientific, Inc. | Implantable materials having engineered surfaces made by vacuum deposition and method of making same |
| US20100070020A1 (en) | 2008-06-11 | 2010-03-18 | Nanovasc, Inc. | Implantable Medical Device |
| CN102499798A (zh) * | 2011-09-29 | 2012-06-20 | 微创医疗器械(上海)有限公司 | 一种介入医疗器械及其制备方法 |
| CN102397119A (zh) * | 2011-09-29 | 2012-04-04 | 微创医疗器械(上海)有限公司 | 一种介入医疗器械及其制备方法 |
| US10566883B2 (en) * | 2012-02-24 | 2020-02-18 | Nissan Motor Co., Ltd. | Sliding contact member, and DC motor and generator using said sliding contact member |
| US8992761B2 (en) * | 2012-07-13 | 2015-03-31 | Abbott Cardiovascular Systems, Inc. | Methods for passivating metallic implantable medical devices including radiopaque markers |
| JP7145757B2 (ja) * | 2015-10-12 | 2022-10-03 | リフロー メディカル インコーポレイテッド | 突出する薬剤送達フィーチャーを有するステント、ならびに、関連のシステムおよび方法 |
| KR102428943B1 (ko) * | 2020-10-08 | 2022-08-03 | 연세대학교 산학협력단 | 약물 전달 스텐트, 이의 제조 방법 및 이를 이용한 약물 전달 방법 |
| EP4529897A1 (de) * | 2023-09-29 | 2025-04-02 | Institut für Implantattechnologie und Biomaterialien e.V. | Implantat zur wiederherstellung der durchgängigkeit und funktionalität des eileiters im reproduktionsgeschehen |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
| US6206916B1 (en) | 1998-04-15 | 2001-03-27 | Joseph G. Furst | Coated intraluminal graft |
| US6436133B1 (en) | 1998-04-15 | 2002-08-20 | Joseph G. Furst | Expandable graft |
| US8070796B2 (en) * | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
| US6602282B1 (en) | 2000-05-04 | 2003-08-05 | Avantec Vascular Corporation | Flexible stent structure |
| WO2002005863A1 (en) * | 2000-07-14 | 2002-01-24 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent composed of a binary alloy |
| US20020032478A1 (en) | 2000-08-07 | 2002-03-14 | Percardia, Inc. | Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel |
| ATE415916T1 (de) | 2000-09-23 | 2008-12-15 | Boston Scient Scimed Inc | Intravaskulärer stent |
| US20030050692A1 (en) | 2000-12-22 | 2003-03-13 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
| AU2002249826A1 (en) * | 2000-12-22 | 2002-07-30 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
| US6955686B2 (en) | 2001-03-01 | 2005-10-18 | Cordis Corporation | Flexible stent |
| US6790227B2 (en) | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
| US6749629B1 (en) | 2001-06-27 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent pattern with figure-eights |
| US20040249443A1 (en) * | 2001-08-20 | 2004-12-09 | Shanley John F. | Expandable medical device for treating cardiac arrhythmias |
| USD481139S1 (en) | 2001-09-17 | 2003-10-21 | Jomed Nv | Stent wall structure |
| US6776794B1 (en) | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
| US6805707B1 (en) | 2001-12-27 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Stent with improved ring and link pattern |
| WO2003065881A2 (en) * | 2002-02-06 | 2003-08-14 | Orbus Medical Technologies Inc. | Medical device with coating that promotes endothelial cell adherence and differentiation |
| NZ534682A (en) * | 2002-02-15 | 2006-10-27 | Cv Therapeutics Inc | Polymer coating for medical devices |
| DK1521603T3 (da) * | 2002-07-12 | 2011-04-18 | Cook Inc | Coated medicinsk anordning |
| US7255710B2 (en) | 2002-08-06 | 2007-08-14 | Icon Medical Corp. | Helical stent with micro-latches |
| US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
| ES2345814T3 (es) | 2002-12-19 | 2010-10-04 | Invatec S.P.A. | Protesis endoluminal. |
| US20040236414A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
| JPWO2004108201A1 (ja) | 2003-06-02 | 2006-07-20 | ニプロ株式会社 | 血管追従性のよい柔軟なステント |
| EP1711213B1 (de) * | 2004-02-06 | 2014-11-19 | Biotronik VI Patent AG | Implantat zur freisetzung eines wirkstoffs in ein von einem körpermedium durchströmtes gefäss |
| DE102004012837B4 (de) | 2004-03-16 | 2006-09-14 | Admedes Schuessler Gmbh | Stent mit einer Stegstruktur und Verfahren zu dessen Herstellung |
| AU2005260732B2 (en) | 2004-06-30 | 2011-08-25 | Cardinal Health 529, Llc | Intraluminal medical device having asymetrical members |
| US7867272B2 (en) | 2004-10-26 | 2011-01-11 | Cordis Corporation | Stent having twist cancellation geometry |
| JP2006167078A (ja) * | 2004-12-15 | 2006-06-29 | Terumo Corp | 医療用インプラント |
| EP1830902A2 (en) * | 2004-12-30 | 2007-09-12 | Cinvention Ag | Combination comprising an agent providing a signal, an implant material and a drug |
| KR100511618B1 (ko) * | 2005-01-17 | 2005-08-31 | 이경범 | 약물방출 조절형 다층 코팅 스텐트 및 이의 제조방법 |
| WO2006110197A2 (en) * | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
| US20060198869A1 (en) * | 2005-03-03 | 2006-09-07 | Icon Medical Corp. | Bioabsorable medical devices |
| AU2006221046B2 (en) * | 2005-03-03 | 2012-02-02 | Icon Medical Corp. | Improved metal alloys for medical device |
| US20060206138A1 (en) * | 2005-03-09 | 2006-09-14 | Eidenschink Tracee E | Intravascular filter assembly |
-
2008
- 2008-03-04 AU AU2008226624A patent/AU2008226624B2/en not_active Ceased
- 2008-03-04 JP JP2009552832A patent/JP5461202B2/ja not_active Expired - Fee Related
- 2008-03-04 EP EP08731329.2A patent/EP2124817B8/en not_active Not-in-force
- 2008-03-04 WO PCT/US2008/055766 patent/WO2008112458A2/en not_active Ceased
- 2008-03-04 CA CA002680229A patent/CA2680229A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1214108B1 (en) | A porous prosthesis and a method of depositing substances into the pores | |
| US6287628B1 (en) | Porous prosthesis and a method of depositing substances into the pores | |
| US6379381B1 (en) | Porous prosthesis and a method of depositing substances into the pores | |
| JP2010520785A5 (enExample) | ||
| EP1362603B1 (en) | Coated stent for release of active agents | |
| US20070078513A1 (en) | Controllable drug releasing gradient coatings for medical devices | |
| US8518097B2 (en) | Plasticized stent coatings | |
| US20030088307A1 (en) | Potent coatings for stents | |
| US20060025848A1 (en) | Medical device having a coating layer with structural elements therein and method of making the same | |
| US20100119581A1 (en) | Medical Products That Release Pharmaceutically Active Substances | |
| US20090148496A1 (en) | Implants with membrane diffusion-controlled release of active ingredient | |
| US20090276036A1 (en) | Stent | |
| JP2008509742A (ja) | ナノ多孔質層を備える医療用デバイスおよびそれを作製するための方法 | |
| JP2008500845A (ja) | 有益な作用物質のリザーバを有する生体再吸収性ステント | |
| JP2011530347A (ja) | 薬物送達システムおよびその薬物送達システムの製造方法 | |
| WO2004087214A1 (en) | Implantable medical device with beneficial agent concentration gradient | |
| EP1781350A2 (en) | A method of making a coated medical device | |
| EP2289575B1 (de) | Medizinisches Implantat enthaltend eine antioxidative Substanz | |
| EP2498865B1 (en) | Drug eluting composite | |
| US20120239140A1 (en) | Medical product comprising an active coating | |
| DE102006038239A1 (de) | Wirkstoffbeschichtete medizinische Implantate | |
| US20100106234A1 (en) | Medical Devices With Extended Drug Diffusion Pathway | |
| AU2016201035B2 (en) | Drug eluting composite | |
| WO2007040485A1 (en) | Stent covered by a layer having a layer opening | |
| HK1168312B (en) | Drug eluting composite |